Omeros (OMER) Stock Price, Quote, News & History | Benzinga

Omeros Corp (OMER) Stock Price, Quote, News & History

OMERNASDAQ

Trade with Public

Trade with Public

$17.19

At close: Aug 17, 5:00 PM EST

$17.41

0.221.31%

After Hours: Aug 14, 7:59 PM EST

Earnings: Q2 2026 Earnings were released on Wed Aug 12th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 5 days ago

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 2.13M

Day Range

- - -

52 Wk Range

3.94 - 18.14

Market Cap

$1.26B

P/E Ratio

10.41

Dividend Yield

-

Exchange

NASDAQ

RSI

83

Short Interest

22.09%

Days to Cover

9.87

Recent Omeros Corporation News

Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday

Nasdaq Composite gained 200 points on Thursday, while Accelerant Holdings (NYSE: ARX) rose 44.2% after being acquired by Thoma Bravo and reporting strong Q2 results. Other top gainers include Omeros Corp (NASDAQ: OMER), CorMedix Inc (NASDAQ: CRMD), and Hyliion Holdings Corp (NYSE: HYLN).

Avi Kapoor

Why Omeros Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

Omeros Corp (OMER) shares rose 17.2% in pre-market trading after reporting better-than-expected Q2 results. Other gainers include FRGT, SFHG, GXAI, CURI, HLIT, HHS, IVDA, NEXN, GO.

Avi Kapoor

Baker Hughes Posts Upbeat Q2 Earnings, Joins Forte Biosciences, Eikon Therapeutics And Other Big Stocks Moving Higher On Monday

Dow Jones up 400 points on Monday. Baker Hughes Co (BKR) shares rise after positive earnings and technology order. Other big gainers include NIPG, FBRX, TRAX, GENI, BMNR, OMER, ASAN, EIKN, IONQ, and SPT.

Avi Kapoor

Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

US stock futures up, Nasdaq 100 gains 1%. Biohaven (BHVN) shares down after BofA downgrade and enrollment of first patient in phase 3 trial.

Avi Kapoor

Crude Oil Falls 4%; US Consumer Sentiment Rises In June

U.S. stocks slightly up, Dow Jones gains 0.1%. Health care shares jump 2.8%, ON Semiconductor down 20%. Oil down 4%, gold up 1.2%, eurozone and Asian markets closed lower.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-68.67M

Investing Cash Flow (TTM)

136.82M

Financing Cash Flow (TTM)

-68.06M

Free Cash Flow (TTM)

-68.73M

Capital Expenditure (TTM)

-56.00K

Net Change in Cash (TTM)

84.00K

Analyst Trends and Forecast

1

Apr

1

May

2

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.25B

PE Ratio (TTM)

10.41

PE Ratio (FWD)

34.36

PEG Ratio (TTM)

-

PS Ratio (TTM)

35.45

PB Ratio (TTM)

-

Earnings Yield % (TTM)

9.60%

Earnings Yield % (FWD)

2.91%

EV / EBITDA (TTM)

133.79

Price / EBITDA (TTM)

145.72

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.71

Company Debt

Total Debt

$128.51M

LT Debt

$97.25M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$108.60M

Total Cash

$1.99M

Debt to Equity

-

Issuance of Debt (TTM)

-$108.60M

Repayment of Debt (TTM)

-$108.60M

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 2.13M

Day Range

- - -

52 Wk Range

3.94 - 18.14

Market Cap

$1.26B

P/E Ratio

10.41

Dividend Yield

-

Exchange

NASDAQ

RSI

83

Short Interest

22.09%

Days to Cover

9.87

About

Sector

Health Care

Industry

Pharmaceuticals

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Omeros (OMER) stock?

A

You can purchase shares of Omeros (NASDAQ:OMER) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Omeros (OMER) competitors?

A

Other companies in Omeros’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Omeros (OMER) stock?

A

Omeros has a consensus price target of $26.40.

Q

What is the current price for Omeros (OMER)?

A

The stock price for Omeros (NASDAQ: OMER) is $17.4144 last updated August 14, 2026 at 7:59 PM EDT.

Q

Does Omeros (OMER) pay a dividend?

A

There are no upcoming dividends for Omeros.

Q

When is Omeros (NASDAQ:OMER) reporting earnings?

A

Omeros does not have any upcoming earnings scheduled.

Q

Is Omeros (OMER) going to split?

A

There is no upcoming split for Omeros.

Q

What sector and industry does Omeros (OMER) operate in?

A

Omeros is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.